| 2.50 Data as of May 24 |  -0.07 / -2.72%Today’s Change | 2.06 Today|||52-Week Range 4.93 | -10.71% Year-to-Date |
| Medivation Loss Narrower Than Expected - Analyst Blog May 13 / Zacks.com |
| Previous close | 2.57 |
| Today’s open | 2.52 |
| Day’s range | 2.48 - 2.56 |
| Volume | 110,793 |
| Average volume (3 months) | 299,892 |
| Market cap | $167.9M |
| Dividend yield | -- |
| Earnings growth (last year) | +9.84% |
| Earnings growth (this year) | +20.18% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -12.88% |
| P/E ratio | NM |
| Price/Sales | 18.87 |
| Price/Book | 25.53 |
| Today’s change | Today’s % change | |
|---|---|---|
| SLTMSolta Medical Inc | +0.02 | +0.94% |
| UTMDUtah Medical Product... | -0.06 | -0.12% |
| ROCMRochester Medical Co... | 0.00 | 0.00% |
| RMTIRockwell Medical Inc | -0.18 | -4.55% |
| Next reporting date | August 12, 2013 |
| EPS forecast (this quarter) | -$0.13 |
| Annual revenue (last year) | $8.7M |
| Annual profit (last year) | -$32.3M |
| Net profit margin | -370.64% |
Sector Health Technology |
Industry Biotechnology |
Vice Chairman & Chief Executive Officer Christopher J. Calhoun, MBA |
President & Director Marc H. Hedrick, MD |
Corporate headquarters San Diego, California |
.
